Most GLP-1 programmes lose 30–50% of patients in the first six months. SureMediks closes the gap between visits with continuous monitoring, automated workflows, and our registered AI engine, Realistic Intelligence — No more artificial® — so adherence stops being a coin flip.
The clinical concern that pharma medical affairs, payers, and aging-population specialists are quietly sounding alarms about: GLP-1 therapy without active body-composition tracking, direct fat-metabolism measurement, and nutrition management drives lean-mass loss that accelerates sarcopenia, frailty, and metabolic dysfunction. SureMediks is built to prevent it — measuring body composition, BHB ketones, and nutrition together, not weight alone.
SureMediks captures both halves of the body-composition picture: the smart scale measures weight, body-fat percentage, and lean muscle mass weekly; the integrated ketone meter reads beta-hydroxybutyrate (BHB) directly — confirming fat metabolism rather than inferring it. Providers see the complete picture, not estimated trends.
GLP-1 patients eat dramatically less. What they do eat has to be far denser in protein, fiber, and micronutrients. The SureMediks nutrition manager is engineered specifically for this constraint — not a generic calorie tracker bolted onto an RPM tool.
Click any phase below to see the modules, the data, and what Realistic Intelligence® does — through whichever lens matters to your role.
Most digital-health tools sit on top of clinical workflows and add work. SureMediks sits underneath — encoding your protocols, automating the steps that don't need a human, and routing only the signals that do.
A 30-minute discovery call to map this six-phase walkthrough onto your service lines, EMR environment and value-based care contracts. No pitch deck. A conversation between people who care about between-visit care.